These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32076491)

  • 21. Correction: Verteporfin inhibits gastric cancer cell growth by suppressing adhesion molecule FAT1.
    Kang MH; Jeong GS; Smoot DT; Ashktorab H; Hwang CM; Kim BS; Kim HS; Park YY
    Oncotarget; 2018 Dec; 9(98):37268. PubMed ID: 30647858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correction: Colon cancer-induced interleukin-35 inhibits betacatenin- mediated pro-oncogenic activity.
    Jiang Y; Ma Y; Li R; Sun J
    Oncotarget; 2018 Aug; 9(60):31788. PubMed ID: 30167095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correction: Improved anti-tumor efficacy via combination of oxaliplatin and fibrin glue in colorectal cancer.
    Hu Y; Yu T; Liu X; He Y; Deng L; Guo J; Hua Y; Luo T; Gao X
    Oncotarget; 2020 Sep; 11(37):3484-3485. PubMed ID: 32973972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correction: Resistin promotes tumor metastasis by down-regulation of miR-519d through the AMPK/p38 signaling pathway in human chondrosarcoma cells.
    Tsai CH; Tsai HC; Huang HN; Hung CH; Hsu CJ; Fong YC; Hsu HC; Huang YL; Tang CH
    Oncotarget; 2018 Oct; 9(85):35598. PubMed ID: 30473753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correction: Reversion of resistance to oxaliplatin by inhibition of p38 MAPK in colorectal cancer cell lines: involvement of the calpain / Nox1 pathway.
    Chocry M; Leloup L; Kovacic H
    Oncotarget; 2018 Jun; 9(42):26978-26979. PubMed ID: 29928496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correction: Compliance with the enhanced recovery after surgery protocol and prognosis after colorectal cancer surgery: A prospective cohort study.
    Li L; Jin J; Min S; Liu D; Liu L
    Oncotarget; 2017 Oct; 8(52):90605. PubMed ID: 29163855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correction: Aloe-emodin inhibits HER-2 expression through the downregulation of Y-box binding protein-1 in HER-2-overexpressing human breast cancer cells.
    Ma JW; Hung CM; Lin YC; Ho CT; Kao JY; Way TD
    Oncotarget; 2019 Oct; 10(55):5727-5729. PubMed ID: 31620249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correction: Interaction between physical activity,
    Gunathilake MN; Lee J; Cho YA; Oh JH; Chang HJ; Sohn DK; Shin A; Kim J
    Oncotarget; 2018 Oct; 9(79):35027. PubMed ID: 30405892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correction: Frankincense essential oil suppresses melanoma cancer through down regulation of Bcl-2/Bax cascade signaling and ameliorates heptotoxicity via phase I and II drug metabolizing enzymes.
    Hakkim FL; Bakshi HA; Khan S; Nasef MM; Farzand R; Sam S; Rashan L; Al-Baloshi MS; Abdo Hasson SSA; Jabri AA; McCarron PA; Tambuwala MM
    Oncotarget; 2020 Jun; 11(23):2259-2261. PubMed ID: 32577169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correction: Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance.
    Zhitomirsky B; Assaraf YG
    Oncotarget; 2022; 13():585-586. PubMed ID: 35391719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correction: A niche that triggers aggressiveness within BRCA1-IRIS overexpressing triple negative tumors is supported by reciprocal interactions with the microenvironment.
    Ryan D; Sinha A; Bogan D; Davies J; Koziol J; ElShamy WM
    Oncotarget; 2017 Dec; 8(68):113294. PubMed ID: 29350211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correction: Neferine inhibits proliferation and collagen synthesis induced by high glucose in cardiac fibroblasts and reduces cardiac fibrosis in diabetic mice.
    Liu X; Song X; Lu J; Chen X; Liang E; Liu X; Zhang M; Zhang Y; Du Z; Zhao Y
    Oncotarget; 2022; 13():810-811. PubMed ID: 35720976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correction: A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11.
    Satake H; Sunakawa Y; Miyamoto Y; Nakamura M; Nakayama H; Shiozawa M; Makiyama A; Kobayashi K; Kubota Y; Mori M; Kotaka M; Takagane A; Gotoh M; Takeuchi M; Fujii M; Ichikawa W; Sekikawa T
    Oncotarget; 2018 Jul; 9(52):30023. PubMed ID: 30042830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correction: Silence of cancer susceptibility candidate 9 inhibits gastric cancer and reverses chemoresistance.
    Shang C; Sun L; Zhang J; Zhao B; Chen X; Xu H; Huang B
    Oncotarget; 2022; 13():684-685. PubMed ID: 35574219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correction: The role of AP-1 in self-sufficient proliferation and migration of cancer cells and its potential impact on an autocrine/paracrine loop.
    El-Fattah Ibrahim SA; Abudu A; Johnson E; Aftab N; Conrad S; Fluck M
    Oncotarget; 2019 Jan; 10(7):799. PubMed ID: 30774782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correction: TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT.
    Li X; Teng S; Zhang Y; Zhang W; Zhang X; Xu K; Yao H; Yao J; Wang H; Liang X; Hu Z
    Oncotarget; 2019 Nov; 10(60):6540. PubMed ID: 31741718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correction: Se
    Zhang HN; Feng WL; An CN; Li WG
    Oncotarget; 2018 Nov; 9(92):36542. PubMed ID: 30559936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correction: The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer.
    Evans JP; Winiarski BK; Sutton PA; Jones RP; Ressel L; Duckworth CA; Pritchard DM; Lin ZX; Fretwell VL; Tweedle EM; Costello E; Goldring CE; Copple IM; Park BK; Palmer DH; Kitteringham NR
    Oncotarget; 2019 Jan; 10(6):685. PubMed ID: 30774766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correction: Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cells.
    Yu X; Ai J; Cai L; Jing Y; Wang D; Dong J; Pascal LE; Zhang J; Luo R; Wang Z
    Oncotarget; 2019 Dec; 10(67):7181-7182. PubMed ID: 31903175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correction: Cycling hypoxia affects cell invasion and proliferation through direct regulation of claudin1 / claudin7 expression, and indirect regulation of p18 through claudin7.
    Liu H; Jiang F; Jia X; Lan J; Guo H; Li E; Yan A; Wang Y
    Oncotarget; 2021 Sep; 12(19):1966-1969. PubMed ID: 34548914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.